Table S3.

Medical history (completer analysis set)

	Placebo	Galantamine
Number of patients	322	339
Total number of patients with condition*	282 (87.6%)	295 (87.0%)
Allergic/immunologic	7 (2.2%)	13 (3.8%)
Cardiovascular	213 (66.1%)	211 (62.2%)
Dermatologic	25 (7.8%)	11 (3.2%)
Endocrine and metabolic	99 (30.7%)	103 (30.4%)
Eyes, ears, nose, and throat	94 (29.2%)	104 (30.7%)
Gastrointestinal	93 (28.9%)	87 (25.7%)
Genitourinary	62 (19.3%)	90 (26.5%)
Hemopoietic/lymphatic	11 (3.4%)	12 (3.5%)
Musculoskeletal	102 (31.7%)	113 (33.3%)
Neurologic	65 (20.2%)	71 (20.9%)
Psychiatric	54 (16.8%)	55 (16.2%)
Respiratory	33 (10.2%)	38 (11.2%)

Note:

^*Medical history and/or currently active condition.